Past Events from May 19 – May 21 – ATSConferenceNews.org

← View Featured Industry Sessions

May 2024

Industry Theater
May 19 @ 12:00 pm – 12:30 pm PDT

Should We Be Targeting Eosinophils Regardless of Allergic Status in Patients With Severe Eosinophilic Asthma?

Featured Innovation Hub
May 19 @ 12:15 pm – 12:35 pm PDT

Elevating Asthma Control: Implications for Your Pediatric Patients

Industry Theater
May 19 @ 12:30 pm – 1:00 pm PDT

Implementing Treprostinil Induction Strategies in Pulmonary Arterial Hypertension

Innovation Hub
May 19 @ 12:35 pm – 12:55 pm PDT

Embracing the Changes: New Horizons in Asthma Clinical Trials

Innovation Hub
May 19 @ 12:55 pm – 1:15 pm PDT

How Methapharm Leverages Market Data for Strategic Growth

Innovation Hub
May 19 @ 12:55 pm – 1:15 pm PDT

EVIS X1 with Prof. Felix Herth, MD

Industry Theater
May 19 @ 1:00 pm – 1:30 pm PDT

A Brief Review of Clinical Insights for Identifying and Managing Patients With Eosinophilic Granulomatosis With Polyangiitis (EGPA)

Industry Theater
May 19 @ 1:00 pm – 1:45 pm PDT

Navigating RSV in Adults: Insights into Disease and Vaccination

Industry Theater
May 19 @ 1:00 pm – 2:00 pm PDT

How Would You Address Eosinophilic + Allergic Inflammation in Severe Asthma?

Innovation Hub
May 19 @ 1:15 pm – 1:35 pm PDT

Challenges in Diagnosing Refractory Chronic Cough

Innovation Hub
May 19 @ 1:15 pm – 1:35 pm PDT

Clearing the air: Navigating the diagnosis and management of Bronchiolitis obliterans syndrome (BOS) after lung transplant

Featured Industry Theater
May 19 @ 1:15 pm – 2:00 pm PDT

Pulmonary Alveolar Proteinosis: Pathophysiology, Diagnosis, and Management

Industry Theater
May 19 @ 1:30 pm – 2:15 pm PDT

Disease Characteristics, Treatments, and Outcomes: Recent Findings From a Large, Real-World, PAH Drug Registry

Featured Innovation Hub
May 19 @ 1:35 pm – 1:55 pm PDT

Tools of the Trade: Imaging in ILD

Innovation Hub
May 19 @ 1:35 pm – 1:55 pm PDT

The heterogeneity of COPD pathophysiology and the role of PDE inhibition: focus on inflammation

Evening Symposium
May 19 @ 6:30 pm – 8:00 pm PDT

Stories Behind the Science in Non-Cystic Fibrosis Bronchiectasis: Understanding Disease Burden, Diagnosing Early, and Looking Toward New Management Options

Evening Symposium
May 19 @ 6:30 pm – 9:00 pm PDT

Asymmetrical Nasal High Flow: A New Paradigm in Noninvasive Respiratory Support

Evening Symposium
May 19 @ 6:30 pm – 9:30 pm PDT

Epithelial Cytokines: Connecting the Dots in Severe Asthma, Nasal Polyps, and COPD

Evening Symposium
May 19 @ 6:30 pm – 9:30 pm PDT

Approaches to COPD care: Targeting the ST2 receptor and IL-33 pathway as a potential option for patients at risk of exacerbating

Evening Symposium
May 19 @ 6:30 pm – 9:30 pm PDT

A Recent Development for Adults with Pulmonary Arterial Hypertension

Featured Industry Theater
May 20 @ 11:30 am – 12:00 pm PDT

Asthma Drivers of Disease: the effects of IL-5 on eosinophils and other cell types that contribute to airway remodeling and disease progression.

Industry Theater
May 20 @ 11:30 am – 12:15 pm PDT

New Insights Into Triple Therapy for COPD: A Focus on the Latest Real-World Evidence

Featured Industry Theater
May 20 @ 11:30 am – 12:30 pm PDT

Interstitial Lung Disease: Presentation to Patient Experience

Innovation Hub
May 20 @ 11:35 am – 11:55 am PDT

Treating hyperinflammation as an unmet need in CAP: Investigational agent reparixin and the REPAVID-22 trial

Innovation Hub
May 20 @ 11:35 am – 11:55 am PDT

Bronchoscopic Lung Volume Reduction: High Volume Community Hospital Perspective with Jason Stienecker, DO

Industry Theater
May 20 @ 11:45 am – 12:30 pm PDT

AIRSUPRA® (albuterol 90 mcg/budesonide 80 mcg): A Paradigm Shift

Featured Innovation Hub
May 20 @ 11:55 am – 12:15 pm PDT

Earlier Assessment of Uncontrolled Moderate-to-Severe Asthma. Is There More We Can Do?

Innovation Hub
May 20 @ 11:55 am – 12:15 pm PDT

The heterogeneity of COPD pathophysiology and the role of PDE inhibition: focus on bronchoconstriction

Industry Theater
May 20 @ 12:00 pm – 12:30 pm PDT

Guidance on Mitigating the Risk of Transmitting Respiratory Infections During Nebulization by the COPD Foundation Nebulizer Consortium

Innovation Hub
May 20 @ 12:15 pm – 12:35 pm PDT

VERITAS RCT: Has bronchoscopy finally replaced CT-Guided biopsy?

Innovation Hub
May 20 @ 12:15 pm – 12:35 pm PDT

Veterans in Crisis: Uncovering the Realities of Burn Pit Exposure and DRRD

Industry Theater
May 20 @ 12:30 pm – 1:00 pm PDT

Choose Wisely: ACT™ or AIRQ®?

Innovation Hub
May 20 @ 12:35 pm – 12:55 pm PDT

Ambulation and Long-Term Oxygen Therapy

Innovation Hub
May 20 @ 12:55 pm – 1:15 pm PDT

Incidental Findings: Identifying cancers earlier

Industry Theater
May 20 @ 1:00 pm – 1:30 pm PDT

Breathing Innovation: Inhaled Pirfenidone for the Treatment of Progressive Pulmonary Fibrosis

Featured Industry Theater
May 20 @ 1:00 pm – 1:45 pm PDT

Understanding the Pathophysiology and Burden of COPD With Blood Eosinophils as a Marker of T2 Inflammation – Is it the Time for Precision Medicine in COPD?

Featured Industry Theater
May 20 @ 1:00 pm – 2:00 pm PDT

Clinical Considerations for Sleep Specialists on the Improvement of Wakefulness in Patients With Excessive Daytime Sleepiness

Innovation Hub
May 20 @ 1:15 pm – 1:35 pm PDT

The Role of Single-Use Bronchoscopes in the Bronch Lab with Sonali Sethi, MD

Innovation Hub
May 20 @ 1:15 pm – 1:35 pm PDT

The Healthcare of Today, Looking towards Tomorrow: Digital Innovations and Patient-Centricity

Industry Theater
May 20 @ 1:15 pm – 2:00 pm PDT

COPD and Asthma with Type 2 Inflammation: Distinct Diseases with a Shared Cause

Featured Evening Symposium
May 20 @ 6:30 pm – 7:30 pm PDT

Type 2 Inflammation in the Pathophysiology of Asthma and COPD: What Is It and How Does It Impact Patients?

Featured Evening Symposium
May 20 @ 6:30 pm – 8:30 pm PDT

Exploring the Impact of OFEV® (nintedanib) capsules

Evening Symposium
May 20 @ 6:30 pm – 9:30 pm PDT

Pulmonary Arterial Hypertension Gameshow

Evening Symposium
May 20 @ 6:30 pm – 9:30 pm PDT

Applying Newer Diagnostic and Therapeutic Tools to the Management of the Individual with Nontuberculous Mycobacterial Lung Disease

Evening Symposium
May 20 @ 6:30 pm – 9:30 pm PDT

An Expert Panel on Severe Asthma: From the Epithelium to Better Patient Outcomes

Industry Theater
May 21 @ 11:30 am – 12:00 pm PDT

Navigating the COPD Patient Journey With Nebulized Maintenance Therapy

Featured Industry Theater
May 21 @ 11:30 am – 12:15 pm PDT

Expectations for Oral Corticosteroid Use

Industry Theater
May 21 @ 11:30 am – 12:30 pm PDT

The Importance of a Proactive Approach to the Management of COPD

Innovation Hub
May 21 @ 11:35 am – 11:55 am PDT

Postoperative Prolonged Air Leaks with the Spiration Valve System, Roy Cho, MD

Industry Theater
May 21 @ 11:45 am – 12:30 pm PDT

Building on Foundational Pathways: A New Treatment Option for PAH

Featured Industry Theater
May 21 @ 12:00 pm – 12:30 pm PDT

Holistic Care of the Immunocompromised Pulmonary Patient with EGPA

Industry Theater
May 21 @ 12:30 pm – 1:00 pm PDT

Emerging Pathways to Precision Medicine for Alpha-1 Antitrypsin Deficiency

Innovation Hub
May 21 @ 12:35 pm – 12:55 pm PDT

The heterogeneity of COPD pathophysiology and the role of PDE inhibition: focus on mucociliary dysfunction

Industry Theater
May 21 @ 1:00 pm – 1:45 pm PDT

Understanding EGPA and the Role of Eosinophilic Inflammation

Industry Theater
May 21 @ 1:00 pm – 2:00 pm PDT

Ignite New Thinking in COPD: Exploring Type 2 Inflammation

Industry Theater
May 21 @ 1:15 pm – 2:15 pm PDT

Global Health Inequities in Chronic Respiratory Disease: Challenges and Potential Solutions

Industry Theater
May 21 @ 1:30 pm – 2:15 pm PDT

Machine Learning and Fibrosing Lung Disease: Imaging Biomarker Progress – with Dr. Simon Walsh and Dr. Kevin Brown, moderated by Elizabeth Estes

Evening Symposium
May 21 @ 6:30 pm – 8:00 pm PDT

PATHWAYS in Type 2 Inflammation Global Grant Initiative

Evening Symposium
May 21 @ 6:30 pm – 9:30 pm PDT

Surv.AI Says: Real-World Insights into the Journey for Patients with Pulmonary Arterial Hypertension